Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1766320

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1766320

Veterinary Reference Laboratory Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

PUBLISHED:
PAGES: 136 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Global Veterinary Reference Laboratory Market was valued at USD 4.9 billion in 2024 and is estimated to grow at a CAGR of 10.6% to reach USD 13.3 billion by 2034. A major driver of this growth is the rising incidence of chronic and zoonotic diseases in farm and companion animals. This increase in disease burden has sparked greater demand for diagnostic services, especially as awareness among pet owners regarding early diagnosis of conditions like diabetes, cancer, and parasitic infections continues to grow. In the livestock industry, stricter requirements around food safety and animal health are further encouraging the adoption of advanced testing services.

Veterinary Reference Laboratory Market - IMG1

Public and private investments, driven by regulatory efforts centered on improving animal health management, are fueling the development of diagnostic infrastructure. Expanding networks of veterinary diagnostic laboratories and growing collaborations between clinics and reference facilities are helping to extend services into previously underserved markets. Additionally, a rise in pet insurance coverage is making veterinary diagnostics more financially accessible to pet owners, enhancing the utilization of reference laboratory services and accelerating the market's momentum across both developed and emerging economies.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$4.9 Billion
Forecast Value$13.3 Billion
CAGR10.6%

In 2024, the clinical chemistry segment achieved a valuation of USD 1.8 billion due to the critical role these tests play in analyzing blood and bodily fluids. These tests are essential for assessing internal organ functions, electrolyte levels, and overall metabolic status. They are particularly relevant for detecting chronic diseases such as renal disorders, diabetes, and endocrine conditions in pets and livestock. The growing use of automated, high-throughput analyzers in reference labs has helped deliver quick and accurate results, meeting the increasing demand for both routine and emergency diagnostic services.

The clinical pathology segment captured a 34.6% share in 2024 and remains a cornerstone of veterinary diagnostics. This category includes vital services like hematology, cytology, urinalysis, and chemistry-based tests that help identify various disease conditions in animals. Clinical pathology serves as the first line of evaluation in veterinary healthcare, aiding in everything from routine health monitoring to diagnosing complex illnesses. With chronic and infectious diseases becoming more common, there is heightened reliance on these tests for managing animal health across both clinical and preventive care settings.

U.S. Veterinary Reference Laboratory Market reached USD 1.7 billion in 2024. Its growth is driven by high pet ownership rates, increasing veterinary expenditures, and strong access to modern animal care services. The country's well-established veterinary infrastructure, along with the widespread adoption of pet insurance, is encouraging more frequent diagnostic testing. This environment supports the expansion of advanced reference laboratory services in the country and contributes significantly to the overall market.

Key players operating in the Global Veterinary Reference Laboratory Market include Zoetis, Heska Corporation, IDEXX Laboratories, Thermo Fisher Scientific, Antech Diagnostics (Mars), Virbac, Nova Biomedical, Vaxxinova, Boehringer Ingelheim International, Laboklin, GD Animal Health, Neogen Corporation, and Colorado State University. To strengthen their position in the veterinary reference laboratory market, companies are implementing a range of strategic initiatives. These include expanding their laboratory networks and entering strategic partnerships with veterinary clinics to boost service accessibility. Many firms are also investing in next-generation diagnostic tools and automation to deliver faster, more accurate results. Emerging markets through acquisitions and localized service offerings, allowing them to reach more customers while enhancing operational scalability.

Product Code: 5540

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Technology
    • 2.2.3 Application
    • 2.2.4 Animal type
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Value addition at each stage
    • 3.1.3 Factors affecting the value chain
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing pet adoption for companionship
      • 3.2.1.2 Rising adoption of pet insurance and increasing animal health expenditure
      • 3.2.1.3 Rising number of zoonotic diseases among pet animals
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with diagnostic services
      • 3.2.2.2 Growing demand for POC portable instruments
    • 3.2.3 Opportunities
      • 3.2.3.1 Expansion into emerging markets
      • 3.2.3.2 Increasing demand for livestock and food safety testing
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East and Africa
  • 3.5 Technology and innovation landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers and acquisitions
    • 4.6.2 Partnerships and collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Technology, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Clinical chemistry
  • 5.3 Immunodiagnostics
    • 5.3.1 ELISA
    • 5.3.2 Lateral flow assays
    • 5.3.3 Other immunodiagnostics assays
  • 5.4 Molecular diagnostics
    • 5.4.1 PCR tests
    • 5.4.2 Microarray
    • 5.4.3 Other molecular diagnostic services
  • 5.5 Hematology
  • 5.6 Urinalysis
  • 5.7 Other technologies

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Clinical pathology
  • 6.3 Bacteriology
  • 6.4 Virology
  • 6.5 Parasitology
  • 6.6 Productivity testing
  • 6.7 Pregnancy testing
  • 6.8 Toxicology testing

Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Companion animals
    • 7.2.1 Dogs
    • 7.2.2 Cats
    • 7.2.3 Horses
    • 7.2.4 Other companion animals
  • 7.3 Livestock animals
    • 7.3.1 Cattle
    • 7.3.2 Swine
    • 7.3.3 Poultry
    • 7.3.4 Sheep and goats
    • 7.3.5 Other livestock animals

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Antech Diagnostics
  • 9.2 Boehringer Ingelheim International
  • 9.3 Colorado State University
  • 9.4 GD Animal Health
  • 9.5 Heska Corporation
  • 9.6 IDEXX Laboratories
  • 9.7 Laboklin
  • 9.8 Neogen Corporation
  • 9.9 Nova Biomedical
  • 9.10 Thermo Fisher Scientific
  • 9.11 Virbac
  • 9.12 VCA
  • 9.13 Vaxxinova
  • 9.14 Zoetis
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!